Sherzod Abdullaev

41 ta ish

Republican Specialized Scientific and Practical Medical Center of Nephrology and Kidney Transplantation , Tashkent , Uzbekistan

#1912 Assessment of the dynamics of renal anemia in patients with atrial fibrillation and chronic kidney disease stage IIIb-V during anticoagulant therapy
Ranokhon Igamberdieva, Sherzod Abdullaev
MaqolaHealthcare Systems and Public HealthNephrology Dialysis Transplantation20240 iqtibos
ABI
#2562 Effect of rituximab on post-transplant outcome in highly sensitized patients
Sherzod Abdullaev, Ranokhon Igamberdieva
MaqolaRenal Transplantation Outcomes and TreatmentsNephrology Dialysis Transplantation20240 iqtibos
ABI
#1986 Incidence of renal anemia among patients with atrial fibrillation and chronic kidney disease stage IIIb-V
Ranokhon Igamberdieva, Sherzod Abdullaev
MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 iqtibos
ABI
#1994 Analysis of dynamics of parameters of safety and effectiveness of rivaroxaban in patients with stage IV chronic kidney disease and atrial fibrillation
Ranokhon Igamberdieva, Sherzod Abdullaev
MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 iqtibos
ABI
#377 Assessment of kidney function by creatinine and cystatin C and cardiovascular outcomes in patients with atrial fibrillation
Sherzod Abdullaev, Ranokhon Igamberdieva
MaqolaBlood Pressure and Hypertension StudiesNephrology Dialysis Transplantation20240 iqtibos
ABI
#150 Effect of dapagliflozin in patients with CKD depending on primary kidney disease
Sherzod Abdullaev, Botir Daminov, Olimkhon Sharapov
MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20240 iqtibos
ABI
#206 The effect of dapagliflozin on anemia in patients with CKD
Sherzod Abdullaev, Ranokhon Igamberdieva
MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20240 iqtibos
ABI
WCN25-3811 PROGRESSION OF ANTICOAGULANT-RELATED NEPHROPATHY AFTER ANTICOAGULANT THERAPY
Sherzod Abdullaev, Ranokhon Igamberdieva
MaqolaAmyloidosis: Diagnosis, Treatment, OutcomesKidney International Reports20250 iqtibos
ABI
Nephroprotective treatment with dapagliflozin in patients with diabetic kidney disease
Olimkhon Sharapov, Sherzod Abdullaev
MaqolaDiabetes Treatment and ManagementNephrology and Dialysis20250 iqtibos
ABI
#1825 Monitoring of atrial indicators in patients with chronic kidney disease and atrial fibrillation after radio-frequency ablation
Ranokhon Igamberdieva, Sherzod Abdullaev, Музаффар Илхомжон Асомов
MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20250 iqtibos
ABI
#2598 Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease
Rakhimjon Tursunbayev, Sherzod Abdullaev, Музаффар Илхомжон Асомов +1
MaqolaLiver Disease Diagnosis and TreatmentNephrology Dialysis Transplantation20250 iqtibos
ABI
#1857 The efficacy and safety of using various combinations of antithrombotic therapy in patients with AF and ESKD undergoing program hemodialysis
Ranokhon Igamberdieva, Sherzod Abdullaev
MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20250 iqtibos
ABI
#426 Antiproteinuric effects of dapagliflozin in lupus nephritis
Sherzod Abdullaev, Olimkhon Sharapov
MaqolaSystemic Lupus Erythematosus ResearchNephrology Dialysis Transplantation20250 iqtibos
ABI
Abstract 4369641: The impact of renal injury markers on bleeding risk in chronic kidney disease and atrial fibrillation patients receiving rivaroxaban
Ranokhon Igamberdieva, Sherzod Abdullaev
MaqolaAcute Kidney Injury ResearchCirculation20250 iqtibos
ABI
WCN26-6606 A CLINICAL CASE OF PREGNANCY AND CHILDBIRTH OF A DIALYSIS PATIENT FROM A HUSBAND WITH A TRANSPLANTED KIDNEY
Olimkhon Sharapov, Botir Daminov, Sherzod Abdullaev +1
MaqolaPregnancy and Medication ImpactKidney International Reports20260 iqtibos
ABI
WCN26-7478 ASSOCIATION BETWEEN URINARY TUBULAR INJURY MARKERS AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE RECEIVING RIVAROXABAN
Ranokhon Igamberdieva, Sherzod Abdullaev
MaqolaAcute Kidney Injury ResearchKidney International Reports20260 iqtibos
ABI